HK Stock MarketDetailed Quotes

CONSUN PHARMA (01681)

Watchlist
  • 14.760
  • +0.260+1.79%
Not Open May 19 16:07 CST
12.42BMarket Cap10.41P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CONSUN PHARMA (01681) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Kangchen Pharmaceutical Division2.97B86.81%
Yulin Pharmaceutical Division450.85M13.19%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Renal drugs2.4B70.30%
Women and children medicine375.73M10.99%
医用成像对比剂236.85M6.93%
Orthopedic drugs188.37M5.51%
Dermatologic drugs121.21M3.55%
Hepatobiliary drugs68.28M2.00%
Other24.62M0.72%
View all

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China Mainland3.38B99.00%
Other areas34.17M1.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.